Pioneer Fund
Ryan K. is a cofounder and CEO of RTHM, a company focused on improving care for complex illnesses, particularly Long COVID, since June 2018. Additionally, Ryan serves as a Venture Partner at Pioneer Fund and holds a prior position as a Research Scientist in the Snyder Lab at Stanford University School of Medicine from January 2016 to December 2021. Ryan participated in the W22 Batch at Y Combinator in early 2022. Academic credentials include a PhD in Microfluidics and Cell Signaling from ETH Zürich, completed in December 2015.
This person is not in the org chart
This person is not in any teams
This person is not in any offices